|
US2010331812A1
|
|
Pharmaceutical Formulations for Iontophoretic Delivery of an Immunomodulator
|
|
WO2010118153A1
|
|
Controlling drug transport and current in iontophoretic onychomycosis treatment
|
|
WO2010083340A1
|
|
Method and system for mitigating current concentration in electrokinetic drug delivery
|
|
WO2010054356A1
|
|
Pharmaceutical formulations for iontophoretic delivery of a corticosteroid
|
|
US2011245759A1
|
|
Methods of Treating An Infection with Nitric Oxide
|
|
US2008160107A1
|
|
Use of nitric oxide gas to treat blood and blood products
|
|
WO2008048514A2
|
|
Topical nitric oxide as a treatment of autoimmune diseases
|
|
AU2007216942A1
|
|
Method and system for electrokinetic delivery of a substance
|
